Clls price
WebCellectis S.A. ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Trade CLLS with: Price/Earnings ttm 0.00 ; … WebView the latest Cellectis S.A. ADR (CLLS) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Clls price
Did you know?
WebCLLS Stock Price - Cellectis SA operates as a clinical stage biotechnological company, which ... Web2 Likes, 0 Comments - Isa Hijab Bandung (@distributor_gamisbandung) on Instagram: " New Yasmin set Bismillahirohmanirohim... Yeaaaaaa saimahijab lovers siapa nih yang ...
WebMar 10, 2024 · CLLS’s market cap is 110.62 Mil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used … WebHow much is Cellectis Sa stock worth today? ( NASDAQ: CLLS) Cellectis Sa currently has 45,565,810 outstanding shares. With Cellectis Sa stock trading at $2.16 per share, the total value of Cellectis Sa stock (market capitalization) is $98.42M. Cellectis Sa stock was originally listed at a price of $39.30 in Mar 25, 2015.
WebAverage analysts price target $37 Buy rating Cellectis SA is a biopharmaceutical company, which engages in the research and development of genome engineering technology. The company operates through the followingEntry level $16 = Target price $19.50 = Stop loss $15 Significant break above 200ma. Average analysts price target $37 Buy rating ... WebThe CLLS stock price is closed at $ 1.880000 with a total market cap valuation of $ 112.23M (44M shares outstanding). The CLLS is trading on NASDAQ with the sign …
WebCellectis SA (CLLS) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Cellectis SA (CLLS) Stock Price & Analysis. Follow. 766 Followers. Portfolio. CLLS Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 - $0. 52-Week ...
WebMar 20, 2024 · The average 12-month price objective among analysts that have issued a report on the stock in the last year is $9.71. CLLS has been the topic of a number of recent research reports. premature playoff nflWebApr 8, 2024 · 6 Wall Street analysts have issued twelve-month price targets for Cellectis' stock. Their CLLS share price forecasts range from $2.00 … scotland company searchWebMar 17, 2024 · The Cellectis S.A. stock price gained 1.08% on the last trading day (Friday, 17th Mar 2024), rising from $1.86 to $1.88. During the last trading day the stock fluctuated 5.00% from a day low at $1.80 to a day high of $1.89. The price has been going up and down for this period, and there has been a -11.74% loss for the last 2 weeks. premature puberty in boysWebApr 6, 2024 · According to 10 analysts, the average rating for CLLS stock is "Buy." The 12-month stock price forecast is $23.95, which is an increase of 1,163.85% from the latest price. premature phototherapy guidelinesWebMar 22, 2024 · Cellectis S.A. American Depositary Shares (CLLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to main … scotland company lawWebGet the latest Cellectis SA (CLLS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. scotland computerWebApr 12, 2024 · More News & Analysis on CLLS. ... Cellectis price target lowered to $16 from $24 at Citi. CLLS. Cellectis enters into warrant agreement with the European Investment Bank related to credit facility agreement and announces the drawdown of the first tranche of €20 million. CLLS. premature puberty in toddlers
![Isa Hijab Bandung on Instagram: "🎀New Yasmin set🎀 ...](https://ts2.mm.bing.net/th?q=Isa Hijab Bandung on Instagram: "🎀New Yasmin set🎀 ...)